ALDX Price Targets and Analyst Ratings NASDAQ:ALDX
ALDX Forecast. What You Should Know.
ALDX Historical Ratings and Targets
About Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.